Hologic, Inc., a leading global medical technology company headquartered in the United States, has been at the forefront of women's health since its founding in 1982. With a strong presence in North America, Europe, and Asia, Hologic focuses on innovative solutions in the fields of diagnostics, medical imaging, and surgical products. Renowned for its advanced technologies, Hologic's core offerings include breast health, gynaecological health, and skeletal health solutions, which are distinguished by their precision and efficacy. The company has achieved significant milestones, including pioneering developments in 3D mammography and molecular diagnostics, solidifying its position as a market leader. Hologic's commitment to improving patient outcomes and enhancing healthcare efficiency has earned it numerous accolades, making it a trusted name in the medical technology industry.
How does Hologic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hologic's score of 59 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Hologic, Inc., headquartered in the US, reported total greenhouse gas emissions of approximately 470,680,000 kg CO2e across all scopes. This includes 7,050,000 kg CO2e from Scope 1 emissions and 14,705,000 kg CO2e from Scope 2 emissions (market-based). The majority of their emissions, about 449,925,000 kg CO2e, stem from Scope 3 activities, which encompass a wide range of indirect emissions, including purchased goods and services (approximately 285,558,000 kg CO2e) and upstream transportation and distribution (about 48,597,000 kg CO2e). Hologic has set ambitious climate commitments, aiming for a 30% reduction in Scope 1 and 2 emissions by 2030 from a 2020 baseline. Additionally, they have committed to a more significant target of reducing these emissions by 50% by 2030, with a long-term goal of achieving a 90% reduction by 2050. Furthermore, Hologic aims to reach net-zero emissions across all scopes by 2050, with a 90% reduction in absolute emissions for Scopes 1, 2, and 3. These targets align with the Science Based Targets initiative (SBTi), which has validated Hologic's near-term targets as consistent with the reductions required to limit global warming to 1.5°C. The company is also focused on increasing its sourcing of renewable electricity from 9% in 2020 to 100% by 2030, further enhancing its sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | - | - | - | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hologic is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.